CD8A and psoriasis: Studies have shown that PTPN22 is a potent inhibitor of T cell activation and it is possible that the effect may differ between T cell subpopulations.12 For example we have shown that CD8+ T cells are important for PsA, while this has not been reported in psoriasis.5